~~<i id='FDA6F94891'><strike id='FDA6F94891'><tt id='FDA6F94891'><pre id='FDA6F94891'></pre></tt></strike></i>~~

Home» focus» leisure time

leisure time

author：explore 2025-10-02 04:22:02 Page View：96793

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Reports of telehealth's death have been greatly exaggerated
Next article： Virginia high school admissions case could be legal follow

Wikipedia

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Why Charlie Gard's case is so disturbing to Americans

ConnieYates,motherofterminallyillbabyCharlieGard,carriesastuffedanimalafterdeliveringapetitionofsign

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

What to expect at HLTH 2023, the health care industry conference

AdobeSTAT’sMohanaRavindranathandAnnalisaMerelliwillbeatHLTHinLasVegasandwillbewritingadailyemaildisp